| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Hawaii Pacific X-Ray Corp is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chandler Group is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As a leading national healthcare solutions organization, Premier, Inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. As an industry leader, Premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. We enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. By engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.
Innovative Therapies is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.